Quince Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Quince Therapeutics, Inc. (QNCX) reported Increase (Decrease) in Accounts Payable of $6.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14
- Quince Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $260.00K.
- Quince Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $5.91M, a 26768.18% increase year-over-year.
- Quince Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.15M, a 185.42% decline year-over-year.
- Quince Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.63M.
- Quince Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$940.00K, a 201.40% decline from fiscal 2024.
- Quince Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2024 was $927.00K.
- Quince Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$288.00K.
- Quince Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$5.94M, a 538.27% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $6.17M 10-Q · filed 2026-08-14 | $5.02M derived: sum of 3 quarters · filed 2026-08-14 | $6.65M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $5.91M 10-Q · filed 2026-05-11 | $4.76M derived: sum of 2 quarters · filed 2026-05-11 | $6.39M derived: sum of 3 quarters · filed 2026-05-11 | $4.95M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $477.00K derived: sum of 2 quarters · filed 2026-04-10 | -$962.00K derived: sum of 3 quarters · filed 2026-08-14 | -$940.00K 10-K · filed 2026-04-10 |
| 2025-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $192.00K derived: sum of 2 quarters · filed 2026-08-14 | $214.00K 10-Q · filed 2025-11-12 | $1.56M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.42M 10-Q · filed 2026-08-14 | -$66.00K derived: sum of 3 quarters · filed 2026-08-14 | -$891.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $22.00K 10-Q · filed 2026-05-11 | $1.37M derived: sum of 2 quarters · filed 2026-05-11 | $548.00K derived: sum of 3 quarters · filed 2026-05-11 | $890.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $526.00K derived: sum of 2 quarters · filed 2026-04-10 | $868.00K derived: sum of 3 quarters · filed 2026-04-10 | $927.00K 10-K · filed 2026-04-10 |
| 2024-09-30 | -$825.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$483.00K derived: sum of 2 quarters · filed 2025-11-12 | -$424.00K 10-Q · filed 2025-11-12 | -$551.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $342.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $401.00K 10-Q · filed 2025-08-11 | $274.00K derived: sum of 3 quarters · filed 2025-08-11 | $329.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $59.00K 10-Q · filed 2025-05-13 | -$68.00K derived: sum of 2 quarters · filed 2025-05-13 | -$13.00K derived: sum of 3 quarters · filed 2025-05-13 | -$1.31M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$72.00K derived: sum of 2 quarters · filed 2025-03-24 | -$1.37M derived: sum of 3 quarters · filed 2025-03-24 | -$288.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$1.24M derived: sum of 2 quarters · filed 2024-11-13 | -$161.00K 10-Q · filed 2024-11-13 | -$775.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$216.00K 10-Q · filed 2024-08-13 | -$830.00K derived: sum of 3 quarters · filed 2024-08-13 | -$1.50M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.08M 10-Q · filed 2024-05-13 | $467.00K derived: sum of 2 quarters · filed 2024-05-13 | -$198.00K derived: sum of 3 quarters · filed 2024-05-13 | -$3.68M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$1.28M derived: sum of 2 quarters · filed 2024-04-01 | -$4.76M derived: sum of 3 quarters · filed 2024-04-01 | -$5.94M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$665.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$4.15M derived: sum of 2 quarters · filed 2023-11-14 | -$5.33M 10-Q · filed 2023-11-14 | -$3.30M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$4.66M 10-Q · filed 2023-08-03 | -$2.63M derived: sum of 3 quarters · filed 2023-08-03 | -$6.95M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$1.18M 10-Q · filed 2023-05-15 | $851.00K derived: sum of 2 quarters · filed 2023-05-15 | -$3.46M derived: sum of 3 quarters · filed 2023-05-15 | $886.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$2.28M derived: sum of 2 quarters · filed 2023-03-15 | $2.07M derived: sum of 3 quarters · filed 2023-03-15 | $1.36M 10-K · filed 2023-03-15 |
| 2021-09-30 | -$4.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $35.00K derived: sum of 2 quarters · filed 2022-11-09 | -$675.00K 10-Q · filed 2022-11-09 | -$1.43M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.64M 10-Q · filed 2022-08-09 | $2.88M derived: sum of 3 quarters · filed 2022-08-09 | $2.10M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$710.00K 10-Q · filed 2022-05-10 | -$1.46M derived: sum of 2 quarters · filed 2022-05-10 | -$2.25M derived: sum of 3 quarters · filed 2022-05-10 | -$2.11M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$1.54M derived: sum of 2 quarters · filed 2022-03-01 | -$1.40M derived: sum of 3 quarters · filed 2022-03-01 | $480.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | -$782.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$645.00K derived: sum of 2 quarters · filed 2021-10-29 | $1.23M 10-Q · filed 2021-10-29 | $2.01M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $137.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $2.02M 10-Q · filed 2021-08-06 | $2.80M derived: sum of 3 quarters · filed 2022-03-01 | -$25.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.88M 10-Q · filed 2021-05-06 | $2.66M derived: sum of 2 quarters · filed 2022-03-01 | -$162.00K derived: sum of 3 quarters · filed 2022-03-01 | $3.01M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $780.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.04M derived: sum of 2 quarters · filed 2022-03-01 | $1.13M derived: sum of 3 quarters · filed 2022-03-01 | $2.58M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $349.00K derived: sum of 2 quarters · filed 2020-11-12 | $1.80M 10-Q · filed 2020-11-12 | $1.73M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $4.62M 10-Q · filed 2020-08-14 | $4.55M derived: sum of 3 quarters · filed 2021-03-01 | $4.75M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $1.45M 10-Q · filed 2020-05-12 | $1.38M derived: sum of 2 quarters · filed 2021-03-01 | $1.57M derived: sum of 3 quarters · filed 2021-03-01 | $1.51M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $124.00K derived: sum of 2 quarters · filed 2021-03-01 | $59.00K derived: sum of 3 quarters · filed 2021-03-01 | -$23.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $132.00K derived: sum of 2 quarters · filed 2019-11-12 | $50.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$147.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$82.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |